Meclizine HCL 12.5 mg
Meclizine HCL 12.5 mg is an FDA drug label for the active ingredient MECLIZINE HCL 12.5 MG manufactured by Advance Pharmaceutical Inc. administered by ORAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20171030.
- Generic name
- MECLIZINE HCL 12.5 MG
- Manufacturer
- Advance Pharmaceutical Inc.
- Product type
- HUMAN OTC DRUG
- Route
- ORAL
- Dosage form
- N/A
- NDC
- 17714-117
- Application
- part336
- Label effective
- 20171030
Active ingredients
Indications & Usage
Uses prevents and treats nausea, vomiting, or dizziness due to motion sickness for other uses, consult your doctor
Dosage & Administration
Directions adults & children 12 years and over: 2-4 caplets once daily children under 12 years: ask a doctor
Contraindications
Not available.
Warnings
Warnings Ask a docotor before use if you have glaucoma a breathing problem such as emphysema or chronic bronchitis trouble urinating due to an enlarged prostate gland Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers When using this product you may get drowsy avoid alcoholic drinks alcohol, sedatives and tranquillizers may increase drowsiness be careful when driving a motor vehicle or operating machinery If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Adverse Reactions
Not available.